Skip Navigation LinksHome > March 2014 - Volume 41 - Issue 3 > Duration of Polymerase Chain Reaction–Detectable DNA After T...
Text sizing:
A
A
A
Sexually Transmitted Diseases:
doi: 10.1097/OLQ.0000000000000102
Original Study

Duration of Polymerase Chain Reaction–Detectable DNA After Treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections in Women

Williams, James A. BS*; Ofner, Susan MS*; Batteiger, Byron E. MD*; Fortenberry, J. Dennis MD, MS*; Van Der Pol, Barbara PhD, MPH

Collapse Box

Abstract

Background

To avoid positive results attributable to residual DNA, the Centers for Disease Control and Prevention recommends avoiding repeat testing with nucleic-acid based tests within 3 weeks after treatment of chlamydial (Chlamydia trachomatis [CT]) or gonococcal (Neisseria gonorrhoeae [GC]) infection. We retrospectively analyzed the duration of detectable DNA from a longitudinal cohort of adolescent women after diagnosis and treatment of infection with CT, GC, or Trichomonas vaginalis (TV).

Methods

Vaginal swabs were obtained weekly from young women for up to 12 weeks (observation period) after treatment of CT, GC and TV infections. Swabs were tested using a commercially available first generation nucleic acid amplification test (NAAT) for CT and GC, and a laboratory developed NAAT for TV. Kaplan-Meier statistics were used to estimate median time to the first negative DNA-based polymerase chain reaction (PCR) result.

Results

Observation periods were available for analysis for 195, 82 and 102 treatments for CT, GC, and TV infection, respectively. Median time to a first negative PCR result for CT, GC, and TV was 9 (range 0–84), 6 (0–76), and 7 (0–84) days, and by day 21, 89%, 95%, and 85% were negative, respectively.

Conclusions

Data from this retrospective analysis indicate that greater than 85% of these young women did not have detectable CT, GC, or TV DNA by day 21 post-treatment. This data may be useful to clinicians for patient management and post-treatment testing purposes.

Copyright © 2014 American Sexually Transmitted Diseases Association All rights reserved

Login